Every US company we alert on
5,765 US-listed companies, ranked by market cap. Open any company to see every SEC filing alert we sent for it: 8-K material events, deals, capital raises, results, leadership changes and insider trades.
Sector
| # | Company | Sector | Market cap | Alerts | Latest |
|---|---|---|---|---|---|
| 2079 | Geron CorpNASDAQ: GERN | Life Sciences | $607M | 3 | Financial ResultsNov 4, 2026 |
| 2082 | ArriVent BioPharma, Inc.NASDAQ: AVBP | Life Sciences | $598M | 6 | Financial ResultsNov 9, 2026 |
| 2094 | Climb Bio, Inc.NASDAQ: CLYM | Life Sciences | $584M | 4 | Financial ResultsNov 5, 2026 |
| 2106 | Aclaris Therapeutics, Inc.NASDAQ: ACRS | Life Sciences | $572M | 5 | Clinical Trial DataNov 16, 2026 |
| 2111 | Wave Life Sciences, Inc.NASDAQ: WVE | Life Sciences | $566M | 2 | Financial ResultsOct 27, 2026 |
| 2113 | Sana Biotechnology, Inc.NASDAQ: SANA | Life Sciences | $563M | 2 | Financial ResultsNov 5, 2026 |
| 2126 | Zevra Therapeutics, Inc.NASDAQ: ZVRA | Life Sciences | $550M | 3 | Financial ResultsNov 3, 2026 |
| 2142 | Myriad Genetics IncNASDAQ: MYGN | Life Sciences | $534M | 8 | Stock Plan AmendmentNov 9, 2026 |
| 2149 | Indaptus Therapeutics, Inc.NASDAQ: INDP | Life Sciences | $530M | 4 | Financial ResultsNov 13, 2026 |
| 2154 | Entera Bio Ltd.NASDAQ: ENTX | Life Sciences | $526M | 4 | Financial ResultsNov 6, 2026 |
| 2156 | Crescent Biopharma, Inc.NASDAQ: CBIO | Life Sciences | $525M | 8 | Financial ResultsNov 12, 2026 |
| 2159 | Electra Therapeutics, Inc.NASDAQ: ETRA | Life Sciences | $522M | 7 | Financial ResultsNov 12, 2026 |
| 2166 | Gyre Therapeutics, Inc.NASDAQ: GYRE | Life Sciences | $506M | 3 | Financial ResultsNov 6, 2026 |
| 2182 | Alpha Teknova, Inc.NASDAQ: TKNO | Life Sciences | $489M | 3 | Financial ResultsNov 5, 2026 |
| 2183 | Monopar TherapeuticsNASDAQ: MNPR | Life Sciences | $488M | 5 | Financial ResultsNov 12, 2026 |
| 2187 | Regenxbio Inc.NASDAQ: RGNX | Life Sciences | $484M | 4 | Financial ResultsNov 5, 2026 |
| 2189 | Capricor Therapeutics, Inc.NASDAQ: CAPR | Life Sciences | $483M | 2 | Financial ResultsNov 10, 2026 |
| 2190 | Neurogene Inc.NASDAQ: NGNE | Life Sciences | $482M | 2 | Financial ResultsNov 9, 2026 |
| 2195 | Phathom Pharmaceuticals, Inc.NASDAQ: PHAT | Life Sciences | $478M | 5 | Financial ResultsOct 29, 2026 |
| 2199 | Shattuck Labs, Inc.NASDAQ: STTK | Life Sciences | $475M | 2 | Financial ResultsNov 5, 2026 |
| 2202 | Aquestive Therapeutics, Inc.NASDAQ: AQST | Life Sciences | $473M | 12 | Investor PresentationNov 16, 2026 |
| 2218 | Candel Therapeutics, Inc.NASDAQ: CADL | Life Sciences | $456M | 3 | Capital RaiseNov 12, 2026 |
| 2221 | Ovid Therapeutics Inc.NASDAQ: OVID | Life Sciences | $453M | 2 | Financial ResultsNov 10, 2026 |
| 2225 | Fennec Pharmaceuticals Inc.NASDAQ: FENC | Life Sciences | $450M | 4 | Insider SellingNov 16, 2026 |
| 2226 | DiaMedica Therapeutics Inc.NASDAQ: DMAC | Life Sciences | $449M | 2 | Financial ResultsNov 12, 2026 |
| 2235 | Arvinas, Inc.NASDAQ: ARVN | Life Sciences | $443M | 2 | Financial ResultsNov 3, 2026 |
| 2237 | Evolus, Inc.NASDAQ: EOLS | Life Sciences | $439M | 3 | Earnings CallNov 4, 2026 |
| 2244 | Assembly Biosciences, Inc.NASDAQ: ASMB | Life Sciences | $436M | 6 | Financial ResultsNov 12, 2026 |
| 2246 | BlossomHill Therapeutics, Inc.NASDAQ: BLSM | Life Sciences | $434M | 4 | Financial ResultsNov 12, 2026 |
| 2248 | CytomX Therapeutics, Inc.NASDAQ: CTMX | Life Sciences | $433M | 1 | Financial ResultsNov 5, 2026 |
| 2259 | Avalo Therapeutics, Inc.NASDAQ: AVTX | Life Sciences | $426M | 4 | Capital RaiseNov 5, 2026 |
| 2265 | Tectonic Therapeutic, Inc.NASDAQ: TECX | Life Sciences | $419M | 4 | Financial ResultsNov 5, 2026 |
| 2277 | Prothena Corp Public Ltd CoNASDAQ: PRTA | Life Sciences | $409M | 11 | Insider BuyingNov 10, 2026 |
| 2281 | IRulya Therapeutics Inc.NASDAQ: IRLA | Life Sciences | $405M | 6 | Financial ResultsNov 13, 2026 |
| 2289 | Elite Pharmaceuticals IncOTC: ELTP | Life Sciences | $399M | 4 | Financial ResultsNov 12, 2026 |
| 2295 | Opus Genetics, Inc.NASDAQ: IRD | Life Sciences | $390M | 10 | Financial ResultsNov 10, 2026 |
| 2307 | Relmada Therapeutics, Inc.NASDAQ: RLMD | Life Sciences | $385M | 3 | Leadership ChangeNov 16, 2026 |
| 2308 | CorMedix Inc.NASDAQ: CRMD | Life Sciences | $383M | 8 | Insider BuyingNov 16, 2026 |
| 2310 | Alector, Inc.NASDAQ: ALEC | Life Sciences | $383M | 5 | Financial ResultsNov 5, 2026 |
| 2315 | Puma Biotechnology, Inc.NASDAQ: PBYI | Life Sciences | $379M | 5 | Insider SellingNov 13, 2026 |
| 2334 | Nika Pharmaceuticals, IncOTC: NIKA | Life Sciences | $369M | 1 | Financial ResultsNov 10, 2026 |
| 2335 | CytoDyn Inc.OTC: CYDY | Life Sciences | $368M | 2 | Leadership ChangeOct 19, 2026 |
| 2346 | ARS Pharmaceuticals, Inc.NASDAQ: SPRY | Life Sciences | $361M | 2 | Financial ResultsNov 5, 2026 |
| 2347 | Lyell Immunopharma, Inc.NASDAQ: LYEL | Life Sciences | $360M | 5 | Insider BuyingNov 5, 2026 |
| 2357 | C4 Therapeutics, Inc.NASDAQ: CCCC | Life Sciences | $348M | 4 | Insider SellingNov 13, 2026 |
| 2362 | Rezolute, Inc.NASDAQ: RZLT | Life Sciences | $346M | 7 | Capital RaiseNov 16, 2026 |
| 2363 | Tilray Brands, Inc.NASDAQ: TLRY | Life Sciences | $346M | 2 | Financial ResultsOct 8, 2026 |
| 2379 | Atea Pharmaceuticals, Inc.NASDAQ: AVIR | Life Sciences | $331M | 3 | Financial ResultsNov 9, 2026 |
| 2401 | Larimar Therapeutics, Inc.NASDAQ: LRMR | Life Sciences | $314M | 10 | Financial ResultsNov 16, 2026 |
| 2405 | Enanta Pharmaceuticals IncNASDAQ: ENTA | Life Sciences | $311M | 3 | Financial ResultsNov 16, 2026 |
| 2407 | TRex Bio, Inc.NASDAQ: TRXB | Life Sciences | $310M | 5 | Financial ResultsNov 13, 2026 |
| 2415 | Galectin Therapeutics IncNASDAQ: GALT | Life Sciences | $305M | 2 | Financial ResultsNov 16, 2026 |
| 2417 | Autolus Therapeutics plcNASDAQ: AUTL | Life Sciences | $304M | 2 | Financial ResultsNov 10, 2026 |
| 2418 | Altimmune, Inc.NASDAQ: ALT | Life Sciences | $304M | 8 | Insider BuyingNov 13, 2026 |
| 2425 | Kyverna Therapeutics, Inc.NASDAQ: KYTX | Life Sciences | $301M | 3 | Financial ResultsNov 12, 2026 |
| 2431 | Emergent BioSolutions Inc.NYSE: EBS | Life Sciences | $299M | 7 | Contract WinNov 4, 2026 |
| 2432 | Benitec Biopharma Inc.NASDAQ: BNTC | Life Sciences | $298M | 7 | Financial ResultsNov 13, 2026 |
| 2433 | Century Therapeutics, Inc.NASDAQ: IPSC | Life Sciences | $298M | 3 | Financial ResultsNov 12, 2026 |
| 2448 | Evommune, Inc.NYSE: EVMN | Life Sciences | $294M | 7 | Financial ResultsNov 12, 2026 |
| 2451 | MapLight Therapeutics, Inc.NASDAQ: MPLT | Life Sciences | $293M | 10 | Capital RaiseNov 16, 2026 |
| 2455 | Eikon Therapeutics, Inc.NASDAQ: EIKN | Life Sciences | $292M | 4 | Financial ResultsNov 12, 2026 |
| 2457 | Scribe Therapeutics, Inc.NASDAQ: SCTX | Life Sciences | $291M | 2 | Financial ResultsNov 12, 2026 |
| 2460 | PepGen Inc.NASDAQ: PEPG | Life Sciences | $290M | 3 | Capital RaiseNov 12, 2026 |
| 2465 | X4 Pharmaceuticals, IncNASDAQ: XFOR | Life Sciences | $289M | 5 | Financial ResultsNov 4, 2026 |
| 2466 | Editas Medicine, Inc.NASDAQ: EDIT | Life Sciences | $289M | 5 | Insider SellingNov 13, 2026 |
| 2469 | Cypherpunk Technologies Inc.NASDAQ: CYPH | Life Sciences | $287M | 3 | Financial ResultsNov 16, 2026 |
| 2473 | Agenus IncNASDAQ: AGEN | Life Sciences | $285M | 2 | Financial ResultsNov 5, 2026 |
| 2476 | Fulcrum Therapeutics, Inc.NASDAQ: FULC | Life Sciences | $283M | 2 | Financial ResultsNov 12, 2026 |
| 2481 | Allogene Therapeutics, Inc.NASDAQ: ALLO | Life Sciences | $280M | 2 | Financial ResultsNov 6, 2026 |
| 2492 | Prelude Therapeutics IncNASDAQ: PRLD | Life Sciences | $273M | 2 | Financial ResultsNov 16, 2026 |
| 2499 | SAB Biotherapeutics, Inc.NASDAQ: SABS | Life Sciences | $270M | 2 | Financial ResultsNov 5, 2026 |
| 2503 | Lexeo Therapeutics, Inc.NASDAQ: LXEO | Life Sciences | $267M | 4 | Financial ResultsNov 16, 2026 |
| 2507 | Northwest Biotherapeutics IncOTC: NWBO | Life Sciences | $265M | 2 | Financial ResultsNov 13, 2026 |
| 2516 | Ocugen, Inc.NASDAQ: OCGN | Life Sciences | $262M | 10 | Licensing DealNov 10, 2026 |
| 2517 | Inovio Pharmaceuticals, Inc.NASDAQ: INO | Life Sciences | $262M | 5 | Financial ResultsNov 10, 2026 |
| 2520 | Turn Therapeutics Inc.NASDAQ: TTRX | Life Sciences | $261M | 4 | Investor PresentationNov 10, 2026 |
| 2527 | Protalix BioTherapeutics, Inc.NYSE: PLX | Life Sciences | $255M | 2 | Financial ResultsNov 10, 2026 |
| 2532 | Usana Health Sciences IncNYSE: USNA | Life Sciences | $250M | 3 | Financial ResultsNov 12, 2026 |
| 2533 | Quoin Pharmaceuticals Ltd.NASDAQ: QNRX | Life Sciences | $250M | 7 | Other 8-K FilingNov 12, 2026 |
| 2538 | Q32 Bio Inc.NASDAQ: QTTB | Life Sciences | $248M | 6 | Financial ResultsNov 4, 2026 |
| 2542 | Standard Biotools Inc.NASDAQ: LAB | Life Sciences | $245M | 6 | M&A DealNov 16, 2026 |
| 2543 | Mereo BioPharma Group plcNASDAQ: MREO | Life Sciences | $244M | 2 | Financial ResultsNov 9, 2026 |
| 2545 | Lifecore Biomedical, Inc. \De\NASDAQ: LFCR | Life Sciences | $243M | 6 | M&A DealNov 5, 2026 |
| 2546 | Camp4 Therapeutics CorpNASDAQ: CAMP | Life Sciences | $242M | 3 | Financial ResultsNov 5, 2026 |
| 2548 | Rocket Pharmaceuticals, Inc.NASDAQ: RCKT | Life Sciences | $241M | 6 | Insider SellingNov 12, 2026 |
| 2550 | BioAge Labs, Inc.NASDAQ: BIOA | Life Sciences | $240M | 3 | Financial ResultsNov 5, 2026 |
| 2551 | Faeth Therapeutics, Inc.NASDAQ: FTH | Life Sciences | $240M | 6 | Clinical Trial DataNov 9, 2026 |
| 2555 | Arcturus Therapeutics Holdings Inc.NASDAQ: ARCT | Life Sciences | $240M | 4 | Capital RaiseNov 16, 2026 |
| 2556 | Cabaletta Bio, Inc.NASDAQ: CABA | Life Sciences | $239M | 4 | Clinical Trial DataNov 9, 2026 |
| 2570 | Canopy Growth CorpNASDAQ: CGC | Life Sciences | $231M | 6 | Financial ResultsNov 6, 2026 |
| 2573 | Vanda Pharmaceuticals Inc.NASDAQ: VNDA | Life Sciences | $230M | 3 | Insider BuyingNov 5, 2026 |
| 2601 | Vogenx, Inc.NASDAQ: VOGX | Life Sciences | $214M | 4 | Financial ResultsNov 6, 2026 |
| 2603 | Yarrow Bioscience, Inc.NASDAQ: YARW | Life Sciences | $212M | 3 | Financial ResultsNov 13, 2026 |
| 2616 | Siga Technologies IncNASDAQ: SIGA | Life Sciences | $205M | 2 | Financial ResultsNov 9, 2026 |
| 2620 | Inhibikase Therapeutics, Inc.NASDAQ: IKT | Life Sciences | $203M | 3 | Financial ResultsNov 10, 2026 |
| 2621 | Precision Biosciences IncNASDAQ: DTIL | Life Sciences | $203M | 6 | Insider SellingNov 12, 2026 |
| 2626 | Lineage Cell Therapeutics, Inc.NYSE: LCTX | Life Sciences | $201M | 3 | Insider BuyingNov 17, 2026 |
| 2630 | Liminatus Pharma, Inc.NASDAQ: LIMN | Life Sciences | $199M | 2 | Capital RaiseNov 3, 2026 |
| 2635 | Keros Therapeutics, Inc.NASDAQ: KROS | Life Sciences | $197M | 6 | Stock BuybackNov 16, 2026 |
| 2639 | Artiva Biotherapeutics, Inc.NASDAQ: ARTV | Life Sciences | $196M | 10 | Business UpdateNov 9, 2026 |